P2Y12 Inhibitors and Acute Coronary Syndrome Management

This chapter focuses on the use of P2Y12 inhibitors in acute coronary syndrome, emphasizing the timing and selection of these medications in consultation with cardiology. It explores the evolution of antiplatelet and anticoagulation practices, including the comparative effectiveness of heparin types and considerations for patients on existing anticoagulants. Additionally, the chapter covers strategies for managing myocardial ischemia and highlights the importance of guideline-directed medical therapy.